Skip to main content
. 2023 Dec 13;12(24):7646. doi: 10.3390/jcm12247646

Figure 2.

Figure 2

Overall survival of patients from time of diagnosis with gastroenteropancreatic neuroendocrine neoplasms metastatic to both liver and bone, compared according to whether liver-directed therapy was given.